Search results
Full body scans miss the mark when it comes to improving U.S. disease prevention
NPR· 21 hours agoCenters estimated that over 100 million Americans don’t have reliable access to primary care, the usual source for most preventive care. I’ve seen the consequences: a delayed breast
AstraZeneca’s lung cancer drug approved by US FDA for combination chemotherapy treatment | Invezz
Invezz· 2 days agoAstraZeneca, the largest pharmaceutical group in Britain, announced that the U.S. Food and Drug...
WHO blames 4 major industries for 2.7 mn deaths a year in Europe
Medical Xpress· 7 days agoThe WHO on Wednesday blamed four major industries—tobacco, ultra-processed foods (UPFs), fossil fuel...
AI Enhances Readability of Cancer Information for Patients
Medscape· 2 days agoChatGPT improved the readability of cancer-related information on patient-facing websites, without...
Full body scans miss the mark when it comes to improving U.S. disease prevention
KPBS San Diego· 1 day agoAnother promises to make cancer “easier to beat” and claims it can detect “over 500 other conditions...
‘Not me watching this while eating a hot dog’: Cancer dietitian shares which grocery store meats are...
The Daily Dot· 6 days agoA registered dietitian nutritionist, who specializes in oncology nutrition, shared which grocery...
The #1 Anti-Inflammatory Frozen Food to Buy at Costco
Eating Well via Yahoo News· 21 hours agoAnd the anti-inflammatory properties are no joke—research suggests that due to the anti-inflammatory...
What is the water deprivation test for diabetes insipidus?
Medical News Today· 5 days agoA water deprivation test checks how the body responds to several hours without water intake. A...
‘A study to give us hope’: Lifestyle changes improve Alzheimer’s symptoms for some
CNN via Yahoo News· 22 hours agoFollowing a vegan diet, reducing stress, exercising and sharing feelings with others helped people...
Gateway - Quartz
Quartz· 14 hours agoNovo Nordisk responded today to the U.S. Federal Trade Commission’s (FTC) suggestion that it filed ‘junk’ patents to prevent competition and raise prices. The Ozempic maker denied wrongdoing ...